A STUDY TO COMPARE ABT-494 TO PLACEBO IN SUBJECTS WITH RHEUMATOID ARTHRITIS ON STABLE DOSE OF CONVENTIONAL SYNTHETIC DISEASE-MODIFYING ANTIRHEUMATIC DRUGS (CSDMARDS) WHO HAVE AN INADEQUATE RESPONSE OR INTOLERANCE TO BIOLOGIC DMARDS: